Longitudinal population studies strategic prioritisation exercise
UK Research and Innovation’s Longitudinal population studies strategic prioritisation exercise gathers detailed data on biomedical LPS to guide future research infrastructure and investment priorities.
Funder: UK Research and Innovation
Due Dates: November 17, 2026 (Closing date)
Funding Amounts: No direct funding; submissions inform future MRC investment. Typical future support: up to £1M/year (Phase 1), £200k/year (Phase 2), lower for Phase 3.
Summary: Strategic exercise to map existing biomedical longitudinal population studies (LPS) and inform future UKRI/MRC infrastructure funding for 2029–2039.
Key Information: Participation will not result in immediate funding; essential for those seeking future MRC LPS support.
Description
This strategic prioritisation exercise, led by the Medical Research Council (MRC) under UK Research and Innovation (UKRI), aims to collect detailed information about existing biomedical longitudinal population studies (LPS) in the UK and internationally. The data gathered will inform future investment decisions and infrastructure planning for LPS over the next decade (2029–2039). The exercise is not a funding competition but a critical step in shaping future MRC support, ensuring the UK maintains world-class, sustainable LPS resources for biomedical research. Submissions are sought from established LPS to help identify strengths, gaps, and priorities across the sector.
